H. Kato

A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer. The Japan Lung Cancer Photodynamic Therapy Study Group.

Kiyoyuki Furuse, M. Fukuoka, H. Kato et al. · Journal of Clinical Oncology · 1993 · 284 citations

Medicine, Oncology, Pharmacology +10

Role of tyrosine kinase activity in signal transduction by the insulin-like growth factor-I (IGF-I) receptor. Characterization of kinase-deficient IGF-I receptors and the action of an IGF-I-mimetic antibody (alpha IR-3).

H. Kato, Teresa N. Faria, Bethel Stannard et al. · Journal of Biological Chemistry · 1993 · 246 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +16

EGFR regulation by microRNA in lung cancer: correlation with clinical response and survival to gefitinib and EGFR expression in cell lines

Glen J. Weiss, Lynne Bemis, Eri Nakajima et al. · Annals of Oncology · 2008 · 241 citations

Medicine, Molecular Biology, Oncology +17

Temporal profile of heat shock protein 70 synthesis in ischemic tolerance induced by preconditioning ischemia in rat hippocampus

Y. Liu, H. Kato, Naoki Nakata et al. · Neuroscience · 1993 · 159 citations

Medicine, Neurobiology, Neuroscience +14

Essential role of tyrosine residues 1131, 1135, and 1136 of the insulin-like growth factor-I (IGF-I) receptor in IGF-I action.

H. Kato, Teresa N. Faria, Bethel Stannard et al. · Molecular Endocrinology · 1994 · 145 citations · Full text

Life Sciences, Cell Biology, Endocrinology +17